Goodwin advised Verseau Therapeutics on the transaction Verseau Therapeutics closed its partnership agreement with 3SBio Inc. (HKEX:1530) focused on the development and commercialization of novel monoclonal…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now